Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. Oct-Dec 1992;17(4):275-9.
doi: 10.1007/BF03190160.

Pharmacokinetics of Mefloquine in Children Aged 6 to 24 Months

Affiliations
Clinical Trial

Pharmacokinetics of Mefloquine in Children Aged 6 to 24 Months

V Singhasivanon et al. Eur J Drug Metab Pharmacokinet. .

Abstract

The study was carried out in 12 children aged 6 months to 2 years, with uncomplicated falciparum malaria admitted to the Hospital for Tropical Diseases, Bangkok. They were treated with mefloquine in the form of MSP (mefloquine 250 mg+sulfadoxine 500 mg+pyrimethamine 25 mg) at a single dose of 25 mg mefloquine base/kg body weight. All of them were cured (28 days follow-up) with minimal side effects. Pharmacokinetic parameter determination was carried out in 9 cases. The results revealed that MRT, t1/2 and tmax in this study (children 6-24 months old) are comparable to the values in children aged 5-12 years, but shorter than in adult patients. Cmax and AUC in children 6-24 months old are comparable to those in children of 5-12 years, but much higher than in adult patients. Vz/f values in this study are comparable to those in children 5-12 years old, but lower than in adult patients.

Similar articles

See all similar articles

Cited by 6 articles

See all "Cited by" articles

References

    1. Bull World Health Organ. 1983;61(5):809-14 - PubMed
    1. Bull World Health Organ. 1983;61(5):815-20 - PubMed
    1. Am J Trop Med Hyg. 1980 Nov;29(6):1131-7 - PubMed
    1. Bull World Health Organ. 1987;65(2):223-6 - PubMed
    1. Bull World Health Organ. 1983;61(2):299-305 - PubMed

Publication types

LinkOut - more resources

Feedback